{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:23:01Z","timestamp":1792264981109,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014394","name":"Baylor University Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014394","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The immunosuppressive regimen for clinical allogeneic islet transplantation uses beta cell\u2013toxic compounds such as tacrolimus that cause islet graft loss. Previously we reported that the plant-derived steroidal lactone Withaferin A (WA) can protect islet grafts by inhibiting nuclear factor-kappa B (NF-\u03baB). Since the NF-\u03baB signaling pathway is essential for T-cell activation, we hypothesized that long-term WA administration may also provide an immunosuppressive effect. Treatment of BALB\/c donor islets and C57BL\/6N recipients with WA alone resulted in 80% islet graft long-term survival vs. 40% in low-dose FK506-treated mice. In vitro, WA significantly blocked mouse and human T-cell proliferation by CD3\/CD28 bead stimulation and in mixed lymphocyte reaction assay. Treatment of immature dendritic cells with WA prevented their maturation in response to inflammatory stimuli, as seen by decreased expression of CD83 and human leukocyte antigen\u2013DR isotype. Exosomes released by islets treated with WA contained significantly fewer proinflammatory molecules interleukin-6, interleukin-8, monocyte chemoattractant protein-1, interferon-gamma-induced protein-10, inducible nitric oxide synthase, and cyclooxygenase-2. In conclusion, WA treatment not only reduced inflammation but also prolonged allograft survival, possibly through suppression of dendritic cell maturation and T-cell proliferation. WA has the potential to inhibit both the innate and adaptive immune response to prolong allograft survival.<\/jats:p>","DOI":"10.1038\/s41598-021-90181-y","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T06:02:50Z","timestamp":1621576970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Withaferin A inhibits lymphocyte proliferation, dendritic cell maturation in vitro and prolongs islet allograft survival"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5979-7454","authenticated-orcid":false,"given":"Kenjiro","family":"Kumano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazhar A.","family":"Kanak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathab Balaji","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"Blanck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srividya","family":"Vasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0671-9572","authenticated-orcid":false,"given":"Bashoo","family":"Naziruddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"key":"90181_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/nejm200007273430401","volume":"343","author":"AM Shapiro","year":"2000","unstructured":"Shapiro, A. M. et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230\u2013238. https:\/\/doi.org\/10.1056\/nejm200007273430401 (2000).","journal-title":"N. Engl. J. Med."},{"key":"90181_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2147\/dmso.S50789","volume":"7","author":"A Bruni","year":"2014","unstructured":"Bruni, A., Gala-Lopez, B., Pepper, A. R., Abualhassan, N. S. & Shapiro, A. J. Islet cell transplantation for the treatment of type 1 diabetes: Recent advances and future challenges. Diabetes Metab. Syndr. Obes. 7, 211\u2013223. https:\/\/doi.org\/10.2147\/dmso.S50789 (2014).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"90181_CR3","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/j.1600-6143.2011.03977.x","volume":"12","author":"MD Bellin","year":"2012","unstructured":"Bellin, M. D. et al. Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am. J. Transplant. 12, 1576\u20131583. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03977.x (2012).","journal-title":"Am. J. Transplant."},{"key":"90181_CR4","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/j.1600-6143.2007.01889.x","volume":"7","author":"M Sleater","year":"2007","unstructured":"Sleater, M., Diamond, A. S. & Gill, R. G. Islet allograft rejection by contact-dependent CD8+ T cells: Perforin and FasL play alternate but obligatory roles. Am. J. Transplant. 7, 1927\u20131933. https:\/\/doi.org\/10.1111\/j.1600-6143.2007.01889.x (2007).","journal-title":"Am. J. Transplant."},{"key":"90181_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/TP.0b013e31823cab44","volume":"93","author":"KJ Wood","year":"2012","unstructured":"Wood, K. J. & Goto, R. Mechanisms of rejection: Current perspectives. Transplantation 93, 1\u201310. https:\/\/doi.org\/10.1097\/TP.0b013e31823cab44 (2012).","journal-title":"Transplantation"},{"key":"90181_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jamaoncol.2015.5137","volume":"2","author":"SA Acuna","year":"2016","unstructured":"Acuna, S. A. et al. Cancer mortality among recipients of solid-organ transplantation in Ontario, Canada. JAMA Oncol. 2, 463\u2013469. https:\/\/doi.org\/10.1001\/jamaoncol.2015.5137 (2016).","journal-title":"JAMA Oncol."},{"key":"90181_CR7","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.4049\/jimmunol.173.8.4828","volume":"173","author":"OB Herrera","year":"2004","unstructured":"Herrera, O. B. et al. A novel pathway of alloantigen presentation by dendritic cells. J. Immunol. 173, 4828\u20134837. https:\/\/doi.org\/10.4049\/jimmunol.173.8.4828 (2004).","journal-title":"J. Immunol."},{"key":"90181_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.416","author":"N Safinia","year":"2010","unstructured":"Safinia, N., Afzali, B., Atalar, K., Lombardi, G. & Lechler, R. I. T-cell alloimmunity and chronic allograft dysfunction. Kidney Int. Suppl. https:\/\/doi.org\/10.1038\/ki.2010.416 (2010).","journal-title":"Kidney Int. Suppl."},{"key":"90181_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1124\/pr.58.2.6","volume":"58","author":"AS Narang","year":"2006","unstructured":"Narang, A. S. & Mahato, R. I. Biological and biomaterial approaches for improved islet transplantation. Pharmacol. Rev. 58, 194\u2013243. https:\/\/doi.org\/10.1124\/pr.58.2.6 (2006).","journal-title":"Pharmacol. Rev."},{"key":"90181_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/s1462399400001861","volume":"2","author":"T Titus","year":"2000","unstructured":"Titus, T., Badet, L. & Gray, D. W. Islet cell transplantation for insulin-dependant diabetes mellitus: Perspectives from the present and prospects for the future. Expert. Rev. Mol. Med. 2, 1\u201328. https:\/\/doi.org\/10.1017\/s1462399400001861 (2000).","journal-title":"Expert. Rev. Mol. Med."},{"key":"90181_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jim.2016.01.007","volume":"430","author":"S Jutz","year":"2016","unstructured":"Jutz, S. et al. Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-kappaB, NFAT and AP-1. J. Immunol. Methods 430, 10\u201320. https:\/\/doi.org\/10.1016\/j.jim.2016.01.007 (2016).","journal-title":"J. Immunol. Methods"},{"key":"90181_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.it.2013.02.002","volume":"34","author":"S Paul","year":"2013","unstructured":"Paul, S. & Schaefer, B. C. A new look at T cell receptor signaling to nuclear factor-kappaB. Trends Immunol 34, 269\u2013281. https:\/\/doi.org\/10.1016\/j.it.2013.02.002 (2013).","journal-title":"Trends Immunol"},{"key":"90181_CR13","doi-asserted-by":"publisher","first-page":"a000182","DOI":"10.1101\/cshperspect.a000182","volume":"2","author":"S Gerondakis","year":"2010","unstructured":"Gerondakis, S. & Siebenlist, U. Roles of the NF-kappaB pathway in lymphocyte development and function. Cold Spring Harb. Perspect. Biol. 2, a000182. https:\/\/doi.org\/10.1101\/cshperspect.a000182 (2010).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"90181_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41419-018-1295-1","volume":"10","author":"M Hart","year":"2019","unstructured":"Hart, M. et al. miR-34a: A new player in the regulation of T cell function by modulation of NF-kappaB signaling. Cell Death Dis. 10, 46. https:\/\/doi.org\/10.1038\/s41419-018-1295-1 (2019).","journal-title":"Cell Death Dis."},{"key":"90181_CR15","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.2337\/db17-0578","volume":"66","author":"G Yoshimatsu","year":"2017","unstructured":"Yoshimatsu, G. et al. Pancreatic beta-cell-derived IP-10\/CXCL10 isletokine mediates early loss of graft function in islet cell transplantation. Diabetes 66, 2857\u20132867. https:\/\/doi.org\/10.2337\/db17-0578 (2017).","journal-title":"Diabetes"},{"key":"90181_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev-immunol-041015-055700","volume":"36","author":"MFS Lindenbergh","year":"2018","unstructured":"Lindenbergh, M. F. S. & Stoorvogel, W. Antigen presentation by extracellular vesicles from professional antigen-presenting cells. Annu. Rev. Immunol. 36, 435\u2013459. https:\/\/doi.org\/10.1146\/annurev-immunol-041015-055700 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"90181_CR17","doi-asserted-by":"publisher","first-page":"104063","DOI":"10.1016\/j.cellimm.2020.104063","volume":"349","author":"G Benichou","year":"2020","unstructured":"Benichou, G., Wang, M., Ahrens, K. & Madsen, J. C. Extracellular vesicles in allograft rejection and tolerance. Cell Immunol. 349, 104063. https:\/\/doi.org\/10.1016\/j.cellimm.2020.104063 (2020).","journal-title":"Cell Immunol."},{"key":"90181_CR18","doi-asserted-by":"publisher","first-page":"113602","DOI":"10.1016\/j.bcp.2019.08.004","volume":"173","author":"B Hassannia","year":"2020","unstructured":"Hassannia, B., Logie, E., Vandenabeele, P., Vanden Berghe, T. & Vanden Berghe, W. Withaferin A: From ayurvedic folk medicine to preclinical anti-cancer drug. Biochem Pharmacol 173, 113602. https:\/\/doi.org\/10.1016\/j.bcp.2019.08.004 (2020).","journal-title":"Biochem Pharmacol"},{"key":"90181_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215310","author":"R Dutta","year":"2019","unstructured":"Dutta, R., Khalil, R., Green, R., Mohapatra, S. S. & Mohapatra, S. Withania somnifera (Ashwagandha) and withaferin A: Potential in integrative oncology. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20215310 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"90181_CR20","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00125-012-2813-9","volume":"56","author":"JA SoRelle","year":"2013","unstructured":"SoRelle, J. A. et al. Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation. Diabetologia 56, 814\u2013824. https:\/\/doi.org\/10.1007\/s00125-012-2813-9 (2013).","journal-title":"Diabetologia"},{"issue":"Suppl 4","key":"90181_CR21","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1186\/1471-2164-11-S4-S25","volume":"11","author":"A Grover","year":"2010","unstructured":"Grover, A., Shandilya, A., Punetha, A., Bisaria, V. S. & Sundar, D. Inhibition of the NEMO\/IKKbeta association complex formation, a novel mechanism associated with the NF-kappaB activation suppression by Withania somnifera\u2019s key metabolite withaferin A. BMC Genom. 11(Suppl 4), S25. https:\/\/doi.org\/10.1186\/1471-2164-11-S4-S25 (2010).","journal-title":"BMC Genom."},{"key":"90181_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.bcp.2014.08.004","volume":"91","author":"K Heyninck","year":"2014","unstructured":"Heyninck, K., Lahtela-Kakkonen, M., Van der Veken, P., Haegeman, G. & Vanden Berghe, W. Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKbeta. Biochem. Pharmacol. 91, 501\u2013509. https:\/\/doi.org\/10.1016\/j.bcp.2014.08.004 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"90181_CR23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00535-016-1238-5","volume":"52","author":"MA Kanak","year":"2017","unstructured":"Kanak, M. A. et al. A small molecule inhibitor of NF\u03baB blocks ER stress and the NLRP3 inflammasome and prevents progression of pancreatitis. J. Gastroenterol. 52, 352\u2013365. https:\/\/doi.org\/10.1007\/s00535-016-1238-5 (2017).","journal-title":"J. Gastroenterol."},{"key":"90181_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12026-012-8300-z","volume":"53","author":"RA Hopkins","year":"2012","unstructured":"Hopkins, R. A. & Connolly, J. E. The specialized roles of immature and mature dendritic cells in antigen cross-presentation. Immunol. Res. 53, 91\u2013107. https:\/\/doi.org\/10.1007\/s12026-012-8300-z (2012).","journal-title":"Immunol. Res."},{"key":"90181_CR25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ni.2065","volume":"12","author":"A Oeckinghaus","year":"2011","unstructured":"Oeckinghaus, A., Hayden, M. S. & Ghosh, S. Crosstalk in NF-kappaB signaling pathways. Nat. Immunol. 12, 695\u2013708. https:\/\/doi.org\/10.1038\/ni.2065 (2011).","journal-title":"Nat. Immunol."},{"key":"90181_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.taap.2015.09.014","volume":"289","author":"L Gambhir","year":"2015","unstructured":"Gambhir, L. et al. Thiol dependent NF-kappaB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A. Toxicol. Appl. Pharmacol. 289, 297\u2013312. https:\/\/doi.org\/10.1016\/j.taap.2015.09.014 (2015).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"90181_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3727\/096368912X658980","volume":"23","author":"T Itoh","year":"2014","unstructured":"Itoh, T. et al. Elevation of high-mobility group box 1 after clinical autologous islet transplantation and its inverse correlation with outcomes. Cell Transplant. 23, 153\u2013165. https:\/\/doi.org\/10.3727\/096368912X658980 (2014).","journal-title":"Cell Transplant."},{"key":"90181_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.regen.2020.100034","author":"K Kumano","year":"2020","unstructured":"Kumano, K. et al. Characterizing and overcoming innate immunity in beta-cell replacement therapy. J. Immunol. Regen. Med. https:\/\/doi.org\/10.1016\/j.regen.2020.100034 (2020).","journal-title":"J. Immunol. Regen. Med."},{"key":"90181_CR29","doi-asserted-by":"publisher","first-page":"451035","DOI":"10.1155\/2014\/451035","volume":"2014","author":"MA Kanak","year":"2014","unstructured":"Kanak, M. A. et al. Inflammatory response in islet transplantation. Int. J. Endocrinol. 2014, 451035. https:\/\/doi.org\/10.1155\/2014\/451035 (2014).","journal-title":"Int. J. Endocrinol."},{"key":"90181_CR30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/TP.0b013e318195fc33","volume":"87","author":"AM Jackson","year":"2009","unstructured":"Jackson, A. M. et al. Evidence for induced expression of HLA class II on human islets: Possible mechanism for HLA sensitization in transplant recipients. Transplantation 87, 500\u2013506. https:\/\/doi.org\/10.1097\/TP.0b013e318195fc33 (2009).","journal-title":"Transplantation"},{"key":"90181_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bcp.2016.03.018","volume":"110\u2013111","author":"BH Kim","year":"2016","unstructured":"Kim, B. H. et al. Alleviation of collagen-induced arthritis by the benzoxathiole derivative BOT-4-one in mice: Implication of the Th1- and Th17-cell-mediated immune responses. Biochem. Pharmacol. 110\u2013111, 47\u201357. https:\/\/doi.org\/10.1016\/j.bcp.2016.03.018 (2016).","journal-title":"Biochem. Pharmacol."},{"key":"90181_CR32","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1080\/21691401.2018.1446968","volume":"46","author":"MA Khan","year":"2018","unstructured":"Khan, M. A. & Khan, M. J. Nano-gold displayed anti-inflammatory property via NF-kB pathways by suppressing COX-2 activity. Artif. Cells Nanomed. Biotechnol. 46, 1149\u20131158. https:\/\/doi.org\/10.1080\/21691401.2018.1446968 (2018).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"90181_CR33","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1186\/s12885-015-1808-6","volume":"15","author":"PS Simon","year":"2015","unstructured":"Simon, P. S. et al. The NF-kappaB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription. BMC Cancer 15, 770. https:\/\/doi.org\/10.1186\/s12885-015-1808-6 (2015).","journal-title":"BMC Cancer"},{"key":"90181_CR34","doi-asserted-by":"publisher","first-page":"48879","DOI":"10.1074\/jbc.M108658200","volume":"276","author":"AK Cardozo","year":"2001","unstructured":"Cardozo, A. K. et al. A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J. Biol. Chem. 276, 48879\u201348886. https:\/\/doi.org\/10.1074\/jbc.M108658200 (2001).","journal-title":"J. Biol. Chem."},{"key":"90181_CR35","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131028","author":"NW Zammit","year":"2019","unstructured":"Zammit, N. W. et al. A20 as an immune tolerance factor can determine islet transplant outcomes. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.131028 (2019).","journal-title":"JCI Insight."},{"key":"90181_CR36","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nri3156","volume":"12","author":"O Boyman","year":"2012","unstructured":"Boyman, O. & Sprent, J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 12, 180\u2013190. https:\/\/doi.org\/10.1038\/nri3156 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"90181_CR37","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1084\/jem.181.3.1091","volume":"181","author":"L Venkataraman","year":"1995","unstructured":"Venkataraman, L., Burakoff, S. J. & Sen, R. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J. Exp. Med. 181, 1091\u20131099. https:\/\/doi.org\/10.1084\/jem.181.3.1091 (1995).","journal-title":"J. Exp. Med."},{"key":"90181_CR38","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.it.2008.01.009","volume":"29","author":"M Breloer","year":"2008","unstructured":"Breloer, M. & Fleischer, B. CD83 regulates lymphocyte maturation, activation and homeostasis. Trends Immunol. 29, 186\u2013194. https:\/\/doi.org\/10.1016\/j.it.2008.01.009 (2008).","journal-title":"Trends Immunol."},{"key":"90181_CR39","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3389\/fimmu.2019.01312","volume":"10","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. CD83: Activation marker for antigen presenting cells and its therapeutic potential. Front. Immunol. 10, 1312. https:\/\/doi.org\/10.3389\/fimmu.2019.01312 (2019).","journal-title":"Front. Immunol."},{"key":"90181_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00403-007-0743-z","volume":"299","author":"AT Prechtel","year":"2007","unstructured":"Prechtel, A. T. & Steinkasserer, A. CD83: An update on functions and prospects of the maturation marker of dendritic cells. Arch. Dermatol. Res. 299, 59\u201369. https:\/\/doi.org\/10.1007\/s00403-007-0743-z (2007).","journal-title":"Arch. Dermatol. Res."},{"key":"90181_CR41","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/s0161-5890(00)00099-7","volume":"37","author":"TA McKinsey","year":"2000","unstructured":"McKinsey, T. A., Chu, Z., Tedder, T. F. & Ballard, D. W. Transcription factor NF-kappaB regulates inducible CD83 gene expression in activated T lymphocytes. Mol. Immunol. 37, 783\u2013788. https:\/\/doi.org\/10.1016\/s0161-5890(00)00099-7 (2000).","journal-title":"Mol. Immunol."},{"key":"90181_CR42","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/leu.2015.231","volume":"30","author":"TA Seldon","year":"2016","unstructured":"Seldon, T. A. et al. Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation. Leukemia 30, 692\u2013700. https:\/\/doi.org\/10.1038\/leu.2015.231 (2016).","journal-title":"Leukemia"},{"key":"90181_CR43","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.4049\/jimmunol.1700064","volume":"200","author":"KY Wong","year":"2018","unstructured":"Wong, K. Y. et al. CD83 antibody inhibits human B cell responses to antigen as well as dendritic cell-mediated CD4 T cell responses. J. Immunol. 200, 3383\u20133396. https:\/\/doi.org\/10.4049\/jimmunol.1700064 (2018).","journal-title":"J. Immunol."},{"key":"90181_CR44","doi-asserted-by":"publisher","first-page":"7127","DOI":"10.1128\/jvi.74.15.7127-7136.2000","volume":"74","author":"M Kruse","year":"2000","unstructured":"Kruse, M. et al. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J. Virol. 74, 7127\u20137136. https:\/\/doi.org\/10.1128\/jvi.74.15.7127-7136.2000 (2000).","journal-title":"J. Virol."},{"key":"90181_CR45","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/s0092-8674(02)00673-6","volume":"108","author":"Y Fujimoto","year":"2002","unstructured":"Fujimoto, Y. et al. CD83 expression influences CD4+ T cell development in the thymus. Cell 108, 755\u2013767. https:\/\/doi.org\/10.1016\/s0092-8674(02)00673-6 (2002).","journal-title":"Cell"},{"key":"90181_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/TP.0000000000002867","volume":"104","author":"NA Oh","year":"2020","unstructured":"Oh, N. A. et al. Plasmacytoid dendritic cell-driven induction of Treg is strain specific and correlates with spontaneous acceptance of kidney allografts. Transplantation 104, 39\u201353. https:\/\/doi.org\/10.1097\/TP.0000000000002867 (2020).","journal-title":"Transplantation"},{"key":"90181_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fimmu.2012.00123","volume":"3","author":"MB Lutz","year":"2012","unstructured":"Lutz, M. B. Therapeutic potential of semi-mature dendritic cells for tolerance induction. Front. Immunol. 3, 123. https:\/\/doi.org\/10.3389\/fimmu.2012.00123 (2012).","journal-title":"Front. Immunol."},{"key":"90181_CR48","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4110\/in.2015.15.6.269","volume":"15","author":"JE Kim","year":"2015","unstructured":"Kim, J. E. et al. Withaferin A inhibits Helicobacter pylori-induced production of IL-1beta in dendritic cells by regulating NF-kappaB and NLRP3 inflammasome activation. Immune Netw. 15, 269\u2013277. https:\/\/doi.org\/10.4110\/in.2015.15.6.269 (2015).","journal-title":"Immune Netw."},{"key":"90181_CR49","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ptr.5746","volume":"31","author":"PM Purushotham","year":"2017","unstructured":"Purushotham, P. M., Kim, J. M., Jo, E. K. & Senthil, K. Withanolides against TLR4-activated innate inflammatory signalling pathways: A comparative computational and experimental study. Phytother. Res. 31, 152\u2013163. https:\/\/doi.org\/10.1002\/ptr.5746 (2017).","journal-title":"Phytother. Res."},{"key":"90181_CR50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/19382014.2016.1223579","volume":"8","author":"K Kumano","year":"2016","unstructured":"Kumano, K. et al. Pretreatment of donor islets with papain improves allograft survival without systemic immunosuppression in mice. Islets 8, 145\u2013155. https:\/\/doi.org\/10.1080\/19382014.2016.1223579 (2016).","journal-title":"Islets"},{"key":"90181_CR51","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fmicb.2013.00292","volume":"4","author":"A Kodama","year":"2013","unstructured":"Kodama, A., Tanaka, R., Saito, M., Ansari, A. A. & Tanaka, Y. A novel and simple method for generation of human dendritic cells from unfractionated peripheral blood mononuclear cells within 2 days: Its application for induction of HIV-1-reactive CD4(+) T cells in the hu-PBL SCID mice. Front. Microbiol. 4, 292. https:\/\/doi.org\/10.3389\/fmicb.2013.00292 (2013).","journal-title":"Front. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90181-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90181-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90181-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:34:32Z","timestamp":1670038472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90181-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["90181"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-90181-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"assertion":[{"value":"12 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10661"}}